Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain

Neuroscience

Volumn 92, Issue 1, 1999, Pages 281-291

  Morin, S M ^a   Ling, N ^a   Liu, X J ^a   Kahl, S D ^b   Gehlert, D R ^a  

^a ELI LILLY AND COMPANY   (United States)

^b NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

Corticotropin releasing factor; Edinger Westphal nucleus; Immunohistochemistry; Sphenoid nucleus; Supraoptic nucleus; Urocortin

Indexed keywords

CORTICOTROPIN RELEASING FACTOR DERIVATIVE; UROCORTIN;

ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARTICLE; BRAIN STEM; CONTROLLED STUDY; FOREBRAIN; IMMUNOHISTOCHEMISTRY; LOCUS CERULEUS; MALE; MEDIAN EMINENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SUPRAOPTIC NUCLEUS; TISSUE DISTRIBUTION;

ANIMALS; BRAIN; CORTICOTROPIN-RELEASING HORMONE; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 0033000181     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00732-5     Document Type: Article

References (24)

1. Behan D.P., Khongsaly O., Ling N., De Souza E.B. Urocortin interaction with corticotropin-releasing factor (CRF) binding protein (CRF-BP): a novel mechanism for elevating "free" CRF levels in human brain. Brain Res. 725:1996;263-267.
2. Berkenbosch F., Tilders F. Effect of axonal transport blockade on corticotropin-releasing factor immunoreactivity in the median eminence of intact and adrenalectomized rats: relationship between depletion rate and secretory activity. Brain Res. 442:1988;312-320.
3. Chalmers D.T., Lovenberg T.W., De Souza E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 15:1995;6340-6350.
4. Deller T., Leranth C., Frotscher M. Reciprocal connections of lateral septal neurons and neurons in the lateral hypothalamus in the rat: a combined Phaseolus vulgaris-leucoagglutinin and Fluoro-Gold immunocytochemical study. Neurosci. Lett. 168:1994;119-122.
5. Donaldson C.J., Sutton S.W., Perrin M.H., Corrigan A.Z., Lewis K.A., Rivier J.E., Vaughan J.M., Vale W.W. Cloning and characterization of human urocortin. Endocrinology. 137:1996;2167-2170.
6. Guillemin R., Ling N., Vargo T. Radioimmunoassay for α-endorphin and β-endorphin. Biochem. biophys. Res. Commun. 77:1977;361-361.
7. Hara Y., Ueta Y., Isse T., Kabashima N., Shibuya I., Hattori Y., Yamashita H. Increase of urocortin-like immunoreactivity in the rat supraoptic nucleus after dehydration but not food deprivation. Neurosci. Lett. 229:1997;65-68.
8. Hara Y., Ueta Y., Isse T., Kabashima N., Shibuya I., Hattori Y., Yamashita H. Increase of urocortin-like immunoreactivity in the rat hypothalamo-neurohypophysial system after salt loading and hypophysectomy. Neurosci. Lett. 227:1997;127-130.
9. Isshi S. (1972) Classification and identification of neurosecretory granules in the median eminence. In Brain Endocrine Interaction. Median Eminence: Structure and Function (eds Knigge K., Scott D. E. and Weindel A.), pp. 119-141. Karger, Basel.
10. 125I]Tyr°-Corticotropin-releasing factor (CRF) binding to the CRF-binding protein using a scintillation proximity assay. J. Neurosci. Meth. 83:1998;103-111.
11. Klooster J., Beckers H.J.M., Vrensen G.F.J.M, Van der Want J.J.L. The peripheral and central projections of the Edinger-Westphal nucleus in the rat. A light and electron microscopic tracing study. Brain Res. 632:1993;260-273.
12. Kozicz T., Yanaihara H., Arimura A. Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J. comp. Neurol. 391:1998;1-10.
13. McLean I.W., Nakane P.K. Periodate-lysine-paraformaldehyde fixative. A new fixative for immunoelectron microscopy. J. Histochem. Cytochem. 22:1974;1077-1080.
14. Moreau J.-L., Kilpatrick G., Jenck F. Urocortin, a novel neuropeptide with anxiogenic-like properties. NeuroReport. 8:1997;1697-1701.
15. Oki Y., Iwabuchi M., Masuzawa M., Watanabe F., Ozawa M., Iino K., Tominaga T., Yoshimi T. Distribution and concentration of urocortin, and effect of adrenalectomy on its content in rat hypothalamus. Life Sci. 62:1998;807-812.
16. Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmac. Rev. 43:1991;425-473.
17. Parkes D.G., Vaughan J., Rivier J., Vale W., May C.N. Cardiac inotropic actions of urocortin in conscious sheep. Am. J. Physiol. 272:1997;H2115-H2122.
18. Poliak S., Mor F., Conlon P., Wong T., Ling N., Rivier J., Vale W., Steinman L. Stress and autoimmunity: the neuropeptides corticotropin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune system. J. Immun. 158:1997;5751-5756.
19. Primus R.J., Yevich E., Baltazar C., Gallager D.W. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain. Neuropsychopharmacology. 17:1997;308-316.
20. Rivier C., Plotsky P.M. Mediation by corticotropin-releasing factor (CRF) of adenohypophysial hormone secretion. A. Rev. Physiol. 48:1986;475-494.
21. Sawchenko P. E., Imaki T., Potter E., Kovacs K., Imaki J. and Vale W. (1993) The functional neuroanatomy of corticotropin-releasing factor. In Corticotropin-releasing Factor, CIBA Foundation Symp. Vol. 172, pp. 5-29. Wiley, Chichester.
22. Spina M., Merlo-Pich E., Chan R.K., Basso A.M., Rivier J., Vale W., Koob G.F. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science. 273:1996;1561-1564.
23. Turnbull A.V., Vale W., Rivier C. Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats. Eur. J. Pharmac. 303:1996;213-216.
24. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., Rivier J., Sawchenko P.E., Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature. 378:1995;287-292.